Admin Posted December 15, 2017 Share Posted December 15, 2017 Our campaign to gain approval of Xofigo (Radium-223) treatment for prostate cancer in bones has been a success. The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended subsidised access to men who need it. The decision only awaits Cabinet approval. Time to thank those who helped. If you contacted your local member, or the Honourable the Minister, you may wish to thank them for their support. Below is my letter to my local member: Hon. Jane Prentice, MP Assistant Minister for Social Services and Disability Services Dear Assistant Minister In March this year I asked for your support in getting the approval rules changed so a new type of prostate cancer treatment (Xofigo) could be made available to Australian men. You took my concerns to the Hon the Minister for Health. I am pleased to inform you that the minister acted, the rules were changed, and yesterday the Pharmaceutical Benefits Advisory Committee (PBAC) announced that it recommended that Xofigo (Radium-223) be approved for supply under the PBS. This decision will improve the lives of thousands of men over the next few years. On behalf of these men and their families, I thank you for your help. Cheers Jim Jim Marshall Convenor Australian Advanced Prostate Cancer Support Group JimJimJimJim.com 4 Balmore Street Indooroopilly Qld 4068 Link to comment Share on other sites More sharing options...
This topic is now archived and is closed to further replies.